LeonaBio, Inc. (NASDAQ:LONA)
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
No revenue reported, so there is no margin to score.
- Revenue
- $0
- Net income
- -$141.5M
- Net margin
- —
Little or no net debt.
- Total debt
- $577K
- Cash
- $32.3M
- Debt / equity
- 0.02
Comfortably covers what is due within a year.
- Current assets
- $54.8M
- Current liabilities
- $7.8M
- Current ratio
- 7.01
Consumes cash and must keep raising it.
- Operating cash flow
- -$61.9M
- Free cash flow
- -$61.9M
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 4.3M
- Share growth (1y)
- 9.4%
- Cash runway
- 6 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
LONA Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 0.00 | 231.00 K | 68.09 M | 243.00 K | 200.00 K | 243.00 K |
| Gross Profit | 0.00 | -231.00 K | -68.09 M | -243.00 K | -200.00 K | -243.00 K |
| SG&A Expense | 6.58 M | 6.88 M | 3.77 M | 4.05 M | 3.63 M | 5.23 M |
| R&D Expense | 12.70 M | 11.26 M | 6.71 M | 2.58 M | 3.66 M | 4.30 M |
| Operating Expenses | 19.45 M | 17.91 M | 10.48 M | 6.63 M | 7.09 M | 9.29 M |
| Operating Income | -19.45 M | -18.14 M | -78.56 M | -6.87 M | -7.29 M | -9.54 M |
| Pretax Income | -19.01 M | -32.95 M | -82.89 M | -6.61 M | -6.97 M | -9.14 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -19.01 M | -32.95 M | -82.89 M | -6.61 M | -6.97 M | -9.14 M |
| EPS (Basic) | -4.45 | -7.71 | -18.94 | -1.68 | -1.78 | -2.30 |
| EPS (Diluted) | -4.45 | -7.71 | -18.94 | -1.68 | -1.78 | -2.30 |
| Shares Outstanding | 4.28 M | 4.28 M | 4.28 M | 3.94 M | 3.91 M | 3.90 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.